CNST News and Press, Constellation Pharmaceuticals Inc. From 12/29/19

2019 will go down in history as one of the best years ever for the stock market. Biotech stocks , in general, have performed very well. And some biotech stocks have delivered staggering gains. Axsome Therapeutics (NASDAQ: AXSM) , Constellation Pharmaceuticals (NASDAQ: CNST) , and Kodiak...

This has been a great year for the overall stock market and a banner year for a handful of drugmakers that don't even have a product to sell yet.  These three biotech stocks entered 2019 ready to provide market-thumping returns, and they delivered. Let's look at what made them the industry...

Biotech, hands down, wins the race for out-performance in the healthcare sector. Delivering new, valuable medicines has proven to be a winning strategy, even if the growth in their stocks is based on the hope of future drugs. However, this list focuses on the top 10 healthcare stocks in 2019, n...

CAMBRIDGE, Mass., Dec. 13, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., (Nasdaq: CNST) a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced closing of its previously announced underwritten ...

Camber Energy (NYSEMKT: CEI ) +40% . More news on: Camber Energy, Inc., My Size, Inc., Proteostasis Therapeutics, Inc., Stocks on the move, Read more ...

Constellation Pharmaceuticals (NASDAQ: CNST ) prices public offering of 6.5M common shares at $34.50/share, for total gross proceeds of $224.3M. More news on: Constellation Pharmaceuticals, Inc., Healthcare stocks news, Read more ...

CAMBRIDGE, Mass., Dec. 10, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., (Nasdaq: CNST) a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that it has priced an underwritten public of...

Gainers: EQ   +17.3% . SFIX   +12.2% . GNW   +10.1% . MDB   +5.6% . GMDA   +4.0% . More news on: Equillium, Inc., Stitch Fix, Inc., Genworth Financial, Inc., Stocks on the move, Read more ...

Constellation Pharmaceuticals (NASDAQ: CNST ) has filed a prospectus for an unspecified mixed shelf offering. More news on: Constellation Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...

CAMBRIDGE, Mass., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., (Nasdaq: CNST) a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that it has commenced an underwritten public...